Transforming the pharmaceutical industry through services
Posted 3rd February 2012 in Articles, General | Register to comment
Katherine Holland explores how pharma could benefit from adopting a new model and moving to providing overall healthcare.
Vision, innovation and new business models are all key themes during the World Pharma Innovation Congress this week in…
Read the full articleDevice ad-vice: dating vs. commitment: pharma vs. devices
Posted 2nd February 2012 in Articles, General | Register to comment
In the first of a new series on medical device marketing Nancy Beesley highlights the key ways device marketing is different from pharma marketing.
I started in medical advertising more than 20 years ago in a rising star agency that specialized in pharmaceutical marketing…
Read the full articlemHealth Monthly Mashup: Release 8.0 – how to get the most out of mhealth: an interview with Brian Edwards (part 1)
Posted 1st February 2012 in Articles, General, Interviews | Register to comment
Excitedly looking into 2012, Michael Spitz interviews Brian Edwards, Senior mHealth Analyst, reviewer, and project manager. This is the first of the two part interview.
Senior mHealth Analyst Brian T. Edwards (@healthgrid) brings a unique industry-based perspective to iMedicalApps.com…
Read the full articleEditor’s voice: January
Posted 31st January 2012 in Articles, General | Register to comment
We take a look back over the content highlights on January in this month’s Editor’s voice.
The start of 2012 has been unsurprisingly busy at pharmaphorum, as the company has expanded. This means…
Read the full articleAre apps medical devices? Part three: How do you create an app which also creates downloads and engagement?
Posted 31st January 2012 in Articles, General | Register to comment
In the third of their three-part article, Paul Dixey and Sam Walmsley discusses some of the promotional and communications techniques you should consider when marketing your health app.
In part 1 of this series, we included some useful tips and questions to consider when developing an app. In part 2 we reviewed the regulatory…
Read the full articleInfluence of medical writers
Posted 30th January 2012 in Articles, General | 2 comments
Darshan Kulkarni highlights the influence that medical writers have when it comes to prescribing and the implications this can have.
Medical writers write, edit, or develop materials about medicine and health. They do this by gathering, organizing, interpreting and presenting…
Read the full articleExecutive perspectives: Mark Read
Posted 27th January 2012 in Articles, General, Interviews | Register to comment
To launch a new aspect of our “perspectives” interviews, Paul Tunnah talks to Mark Read, CEO of WPP Digital, to hear his insights on digital from the C-level vantage point.
At pharmaphorum, we’re constantly striving to speak to different stakeholders in the healthcare space to hear their perspectives on the industry, with…
Read the full articleCareers Management
Posted 26th January 2012 in Articles, General | Register to comment
Gail Sampson offers tips on how to manage your career within the pharma industry.
Be honest, how often do you think of your career long term? With so much changing in the industry on a day-to-day basis, the likelihood is…
Read the full articleSpotlight on…. pituitary disorders
Posted 25th January 2012 in Articles, General | 4 comments
Retired GP and Pituitary Foundation trustee Dr Mark Pharaoh sheds some light on pituitary disease in the first of a new series that shines a spotlight on different disease areas.
Pituitary disease is an uncommon illness affecting both sexes and all ages and only rarely does it run in families…
Read the full articleAre apps medical devices? Part two: Apps as medical devices – the regulatory framework
Posted 24th January 2012 in Articles, General | Register to comment
Continuing their advice on apps as medical devices Paul Dixey and Sam Walmsley explore the classification system of devices with regards to apps.
In part one of this series we discussed some of the marketing and organisational steps that pharma companies should consider when…
Read the full article